Covered recipient · General Payments record
COURTNEY ANN PIERRON
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2023–2024
$1,384.18
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,056.68 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $207.51 | 2 |
| Medtronic, Inc. | $161.14 | 1 |
| BETA BIONICS, INC. | $153.25 | 2 |
| Insulet Corporation | $122.86 | 1 |
| BioMarin Pharmaceutical Inc. | $121.35 | 1 |
| Tandem Diabetes Care, Inc. | $99.52 | 1 |
| Ascendis Pharma Inc | $83.27 | 1 |
| DEXCOM, INC. | $73.67 | 1 |
| SANOFI-AVENTIS U.S. LLC | $34.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma Inc | $83.27 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133849673 | CMS |
| BETA BIONICS, INC. | $73.33 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087877007 | CMS |
| BETA BIONICS, INC. | $79.92 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087887371 | CMS |
| BioMarin Pharmaceutical Inc. | $121.35 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127062626 | CMS |
| Dexcom, Inc. | $73.67 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153293235 | CMS |
| Insulet Corporation | $122.86 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116801468 | CMS |
| Medtronic, Inc. | $161.14 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119498238 | CMS |
| Novo Nordisk Inc | $119.70 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097612738 | CMS |
| Novo Nordisk Inc | $87.81 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097336189 | CMS |
| SANOFI-AVENTIS U.S. LLC | $34.11 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139844163 | CMS |
| Tandem Diabetes Care, Inc. | $99.52 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138745595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.